Dr. Marwa S. Taha is a distinguished academic and researcher in the Department of Medical Microbiology and Immunology at the Faculty of Medicine, Tanta University. With a robust portfolio in clinical microbiology, she has established herself as a key contributor to the understanding of antimicrobial resistance (AMR) and the molecular characterization of multidrug-resistant (MDR) pathogens in Egypt.
Dr. Taha’s primary research interests focus on the surveillance and genetic analysis of "ESKAPE" pathogens, particularly Klebsiella pneumoniae, Acinetobacter baumannii, and Methicillin-resistant Staphylococcus aureus (MRSA). She has published extensively on the genotypic detection of virulence factors—such as carbapenem-resistance genes and hypervirulent capsular serotypes—contributing vital data to the epidemiological mapping of hospital-acquired infections in the Nile Delta region.
Recognizing the urgent global need for non-antibiotic therapeutic alternatives, Dr. Taha is at the forefront of researching novel antimicrobial modalities. Her recent work includes pioneering studies on Photodynamic Antibacterial Therapy (PDT), investigating the efficacy of red-light-emitting diodes (LEDs) and various photosensitizers against resistant bacterial isolates from skin infections. Additionally, she is actively exploring Nanotechnology, specifically the green biosynthesis of silver nanoparticles (AgNPs) using endophytic fungi, to combat MDR organisms.
Dr. Marwa S. Taha is a distinguished academic and researcher in the Department of Medical Microbiology and Immunology at the Faculty of Medicine, Tanta University. With a robust portfolio in clinical microbiology, she has established herself as a key contributor to the understanding of antimicrobial resistance (AMR) and the molecular characterization of multidrug-resistant (MDR) pathogens in Egypt.
Dr. Taha’s primary research interests focus on the surveillance and genetic analysis of "ESKAPE" pathogens, particularly Klebsiella pneumoniae, Acinetobacter baumannii, and Methicillin-resistant Staphylococcus aureus (MRSA). She has published extensively on the genotypic detection of virulence factors—such as carbapenem-resistance genes and hypervirulent capsular serotypes—contributing vital data to the epidemiological mapping of hospital-acquired infections in the Nile Delta region.
Recognizing the urgent global need for non-antibiotic therapeutic alternatives, Dr. Taha is at the forefront of researching novel antimicrobial modalities. Her recent work includes pioneering studies on Photodynamic Antibacterial Therapy (PDT), investigating the efficacy of red-light-emitting diodes (LEDs) and various photosensitizers against resistant bacterial isolates from skin infections. Additionally, she is actively exploring Nanotechnology, specifically the green biosynthesis of silver nanoparticles (AgNPs) using endophytic fungi, to combat MDR organisms.